Algo version: 0.98b
BGLC is listed at the NASDAQ Exchange
BGLC [BGLC]
NASDAQ Sector: Healthcare Industry:Medical Diagnostics Research

Is BGLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for BioNexus Gene Lab Corp 10 years ago, but if you had invested on Thursday 26th of October 2023 when the price was $0.439, you would have made a loss of $-0.139 per share or -31.63%

No, the average daily trading liquidity for BioNexus Gene Lab Corp is $112 855 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.

BioNexus Gene Lab Corp has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for BioNexus Gene Lab Corp to be medium [0.6 out of 1]